Raúl Moreno1, José-Luis Díez2, José-Antonio Diarte3, Fernando Macaya4, José-María de la Torrre Hernández5, Oriol Rodríguez-Leor6, Ramiro Trillo7, Juan Alonso-Briales8, Ignacio Amat-Santos9, Rafael Romaguera10, José-Francisco Díaz11, Beatriz Vaquerizo12, Soledad Ojeda13, Ignacio Cruz-González14, Daniel Morena-Salas15, Armando Pérez de Prado16, Fernando Sarnago17, Pilar Portero18, Alejandro Gutierrez-Barrios19, Fernando Alfonso20, Eduard Bosch21, Eduardo Pinar22, José-Ramón Ruiz-Arroyo23, Valeriano Ruiz-Quevedo24, Jesús Jiménez-Mazuecos25, Fernando Lozano26, José-Ramón Rumoroso27, Enrique Novo28, Francisco J Irazusta29, Bruno García Del Blanco30, José Moreu31, Sara M Ballesteros-Pradas32, Araceli Frutos33, Manuel Villa34, Eduardo Alegría-Barrero35,36, Rosa Lázaro37, Emilio Paredes38. 1. Hospital Universitario La Paz, IdiPAZ, CIBER-CV, Madrid, Spain. 2. Hospital La Fe, Valencia, Spain. 3. Hospital Miguel Servet, Zaragoza, Spain. 4. Hospital Clínico San Carlos, Madrid, Spain. 5. Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. 6. Hospital German Trias i Pujol, Badalona, Spain. 7. Hospital Clínico Universitario, Santiago de Compostela, Spain. 8. Hospital Virgen de la Victoria, Málaga, Spain. 9. Hospital Clínico Universitario, Valladolid, Spain. 10. Hospital de Bellvitge, Barcelona, Spain. 11. Hospital Juan Ramón Jiménez, Huelva, Spain. 12. Hospital del Mar, Barcelona, Spain. 13. Hospital Reina Sofía, Córdoba, Spain. 14. Hospital Universitario de Salamanca, IBSAL, CIBER CV, Salamanca, Spain. 15. Hospital de Cabueñes, Gijón, Spain. 16. Complejo Hospitalario, León, Spain. 17. Hospital Doce de Octubre, Madrid, Spain. 18. Hospital San Pedro de La Rioja, Logroño, Spain. 19. Hospital Puerta del Mar, Cádiz, Spain. 20. Hospital de La Princesa, Madrid, Spain. 21. Corporació Sanitaria Parc Tauli, Sabadell, Spain. 22. Hospital Virgen de L´Arrixaca, Murcia, Spain. 23. Hospital Lozano Blesa, Zaragoza, Spain. 24. Hospital Clínico de Navarra, Pamplona, Spain. 25. Hospital Universitario, Albacete, Spain. 26. Hospital General Universitario, Ciudad Real, Spain. 27. Hospital de Galdakao, Bilbao, Spain. 28. Hospital Universitario, Guadalajara, Spain. 29. Policlínica de Guipúzcoa, San Sebastian, Spain. 30. Hospital Vall D´Hebron, Barcelona, Spain. 31. Hospital Virgen de la Salud, Toledo, Spain. 32. Hospital de Valme, Sevilla, Spain. 33. Hospital San Juan, Alicante, Spain. 34. Hospital Virgen del Rocío, Sevilla, Spain. 35. Hospital Universitario de Torrejón, Torrejón de Ardoz, Spain. 36. Hospital Ruber Internacional, Madrid, Spain. 37. Hospital de Torrecárdenas, Almería, Spain. 38. pInvestiga, Pontevedra, Spain.
Abstract
BACKGROUND: During COVID-19 pandemic in Spain, elective procedures were canceled or postponed, mainly due to health care systems overwhelming. OBJECTIVE: The objective of this study was to evaluate the consequences of interrupting invasive procedures in patients with chronic cardiac diseases due to the COVID-19 outbreak in Spain. METHODS: The study population is comprised of 2,158 patients that were pending on elective cardiac invasive procedures in 37 hospitals in Spain on the 14th of March 2020, when a state of alarm and subsequent lockdown was declared in Spain due to the COVID-19 pandemic. These patients were followed-up until April 31th. RESULTS: Out of the 2,158 patients, 36 (1.7%) died. Mortality was significantly higher in patients pending on structural procedures (4.5% vs. 0.8%, respectively; p < .001), in those >80 year-old (5.1% vs. 0.7%, p < .001), and in presence of diabetes (2.7% vs. 0.9%, p = .001), hypertension (2.0% vs. 0.6%, p = .014), hypercholesterolemia (2.0% vs. 0.9%, p = .026) [Correction added on December 23, 2020, after first online publication: as per Dr. Moreno's request changes in p-values were made after original publication in Abstract.], chronic renal failure (6.0% vs. 1.2%, p < .001), NYHA > II (3.8% vs. 1.2%, p = .001), and CCS > II (4.2% vs. 1.4%, p = .013), whereas was it was significantly lower in smokers (0.5% vs. 1.9%, p = .013). Multivariable analysis identified age > 80, diabetes, renal failure and CCS > II as independent predictors for mortality. CONCLUSION: Mortality at 45 days during COVID-19 outbreak in patients with chronic cardiovascular diseases included in a waiting list due to cancellation of invasive elective procedures was 1.7%. Some clinical characteristics may be of help in patient selection for being promptly treated when similar situations happen in the future.
BACKGROUND: During COVID-19 pandemic in Spain, elective procedures were canceled or postponed, mainly due to health care systems overwhelming. OBJECTIVE: The objective of this study was to evaluate the consequences of interrupting invasive procedures in patients with chronic cardiac diseases due to the COVID-19 outbreak in Spain. METHODS: The study population is comprised of 2,158 patients that were pending on elective cardiac invasive procedures in 37 hospitals in Spain on the 14th of March 2020, when a state of alarm and subsequent lockdown was declared in Spain due to the COVID-19 pandemic. These patients were followed-up until April 31th. RESULTS: Out of the 2,158 patients, 36 (1.7%) died. Mortality was significantly higher in patients pending on structural procedures (4.5% vs. 0.8%, respectively; p < .001), in those >80 year-old (5.1% vs. 0.7%, p < .001), and in presence of diabetes (2.7% vs. 0.9%, p = .001), hypertension (2.0% vs. 0.6%, p = .014), hypercholesterolemia (2.0% vs. 0.9%, p = .026) [Correction added on December 23, 2020, after first online publication: as per Dr. Moreno's request changes in p-values were made after original publication in Abstract.], chronic renal failure (6.0% vs. 1.2%, p < .001), NYHA > II (3.8% vs. 1.2%, p = .001), and CCS > II (4.2% vs. 1.4%, p = .013), whereas was it was significantly lower in smokers (0.5% vs. 1.9%, p = .013). Multivariable analysis identified age > 80, diabetes, renal failure and CCS > II as independent predictors for mortality. CONCLUSION:Mortality at 45 days during COVID-19 outbreak in patients with chronic cardiovascular diseases included in a waiting list due to cancellation of invasive elective procedures was 1.7%. Some clinical characteristics may be of help in patient selection for being promptly treated when similar situations happen in the future.
Authors: Stefanie Andreß; Tilman Stephan; Dominik Felbel; Alex Mack; Michael Baumhardt; Johannes Kersten; Dominik Buckert; Alexander Pott; Tillman Dahme; Wolfgang Rottbauer; Armin Imhof; Manuel Rattka Journal: Clin Res Cardiol Date: 2022-05-23 Impact factor: 6.138
Authors: Christian Philip Stickels; Ramesh Nadarajah; Chris P Gale; Houyuan Jiang; Kieran J Sharkey; Ben Gibbison; Nick Holliman; Sara Lombardo; Lars Schewe; Matteo Sommacal; Louise Sun; Jonathan Weir-McCall; Katherine Cheema; James H F Rudd; Mamas Mamas; Feryal Erhun Journal: BMJ Open Date: 2022-06-16 Impact factor: 3.006
Authors: Raúl Moreno; José-Luis Díez; José-Antonio Diarte; Pablo Salinas; José María de la Torre Hernández; Juan F Andres-Cordón; Ramiro Trillo; Juan Alonso Briales; Ignacio Amat-Santos; Rafael Romaguera; José-Francisco Díaz; Beatriz Vaquerizo; Soledad Ojeda; Ignacio Cruz-González; Daniel Morena-Salas; Armando Pérez de Prado; Fernando Sarnago; Pilar Portero; Alejandro Gutierrez-Barrios; Fernando Alfonso; Eduard Bosch; Eduardo Pinar; José-Ramón Ruiz-Arroyo; Valeriano Ruiz-Quevedo; Jesús Jiménez-Mazuecos; Fernando Lozano; José-Ramón Rumoroso; Enrique Novo; Francisco J Irazusta; Bruno García Del Blanco; José Moreu; Sara M Ballesteros-Pradas; Araceli Frutos; Manuel Villa; Eduardo Alegría-Barrero; Rosa Lázaro; Emilio Paredes Journal: Cardiovasc Diabetol Date: 2021-03-23 Impact factor: 9.951
Authors: Javier de Miguel-Diez; Rodrigo Jimenez-Garcia; Jose M de Miguel-Yanes; Valentin Hernández-Barrera; David Carabantes-Alarcon; Jose J Zamorano-Leon; Concepción Noriega; Ana Lopez-de-Andres Journal: J Clin Med Date: 2022-07-05 Impact factor: 4.964